Case scenario

You are approached in the pharmacy by a 62-year-old man concerned about a yellow, thickened great toenail that has progressively worsened over 18 months. He reports trying several antifungal paints without improvement and asks for a ‘stronger treatment’. He also has type 2 diabetes and peripheral vascular disease. On examination, the nail appears thickened, brittle and partially separated from the nail bed.

Learning outcomes

After reading this article, pharmacists should be able to:

  • Describe the clinical features and risk factors associated with onychomycosis

  • Discuss the diagnosis, differential diagnosis and treatment options for onychomycosis

  • Explain the limitations of topical therapies and factors contributing to treatment failure or recurrence

  • Describe the role of pharmacists in supporting patients with fungal nail infections.

Competency standards (2016) addressed: 1.4, 1.5, 2.2, 2.3, 3.1, 3.5

Accreditation number: PSAAP2611HN

Accreditation expiry: 31/10/2028

Accreditation points: Up to 1.0 Group 2 credits

Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.

Introduction

Onychomycosis is a fungal infection of the nail that commonly affects toenails, fingernails or both. It accounts for approximately 50% of all nail disorders and is one of the most common nail conditions encountered in

THIS IS A MEMBERS ONLY ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.